rs202120238
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_002471.4(MYH6):c.2383C>T(p.Arg795Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00016 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R795Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_002471.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 14Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
- Keppen-Lubinsky syndromeInheritance: AD Classification: MODERATE Submitted by: Illumina
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- atrial septal defect 3Inheritance: AD Classification: LIMITED Submitted by: G2P
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYH6 | NM_002471.4 | c.2383C>T | p.Arg795Trp | missense_variant | Exon 20 of 39 | ENST00000405093.9 | NP_002462.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152172Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000995 AC: 25AN: 251340 AF XY: 0.000110 show subpopulations
GnomAD4 exome AF: 0.000162 AC: 237AN: 1461800Hom.: 0 Cov.: 32 AF XY: 0.000149 AC XY: 108AN XY: 727190 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000138 AC: 21AN: 152290Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: MYH6 c.2383C>T (p.Arg795Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 9.9e-05 in 251340 control chromosomes. The observed variant frequency is approximately 4 fold of the estimated maximal expected allele frequency for a pathogenic variant in MYH6 causing Cardiomyopathy phenotype (2.5e-05). c.2383C>T has been reported in the literature in an individual affected with hypoplastic left heart syndrome and in a survivor of sudden cardiac arrest due to exercise-related mitral valve prolapse (e.g. Tomita-Mitchell_2016, Asatryan_2019). These report(s) do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 27789736, 28082330, 30975432). ClinVar contains an entry for this variant (Variation ID: 470512). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -
Hypertrophic cardiomyopathy 14 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 795 of the MYH6 protein (p.Arg795Trp). This variant is present in population databases (rs202120238, gnomAD 0.02%). This missense change has been observed in individual(s) with MYH6-related conditions (PMID: 27789736, 28082330, 30975432). ClinVar contains an entry for this variant (Variation ID: 470512). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MYH6 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Dilated cardiomyopathy 1EE;C2750467:Hypertrophic cardiomyopathy 14;C3279790:Atrial septal defect 3;C3279791:Sick sinus syndrome 3, susceptibility to;C3495498:Hypertrophic cardiomyopathy 1 Uncertain:1
- -
Cardiomyopathy Uncertain:1
- -
not provided Uncertain:1
Reported in a proband with hypoplastic left heart syndrome (Tomita-Mitchell et al., 2016) and in a proband with mitral valve prolapse and a history of sudden cardiac arrest in the published literature (Asatryan et al., 2019); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 470512; Landrum et al., 2016); This variant is associated with the following publications: (PMID: 30975432, 27789736) -
Cardiovascular phenotype Uncertain:1
The p.R795W variant (also known as c.2383C>T), located in coding exon 18 of the MYH6 gene, results from a C to T substitution at nucleotide position 2383. The arginine at codon 795 is replaced by tryptophan, an amino acid with dissimilar properties. This alteration has been reported in a hypoplastic left heart syndrome cohort, but clinical details were limited (Tomita-Mitchell A et al. Physiol. Genomics, 2016 12;48:912-921). This alteration has also been reported in a sudden cardiac arrest cohort (Asatryan B et al. Am J Cardiol, 2019 06;123:2031-2038). This variant was also reported in a pediatric cardiomyopathy cohort (Ware SM et al. Am J Hum Genet, 2022 Feb;109:282-298). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at